AU1570995A - Modified papilloma virus l2 protein and vlps formed therefrom - Google Patents
Modified papilloma virus l2 protein and vlps formed therefromInfo
- Publication number
- AU1570995A AU1570995A AU15709/95A AU1570995A AU1570995A AU 1570995 A AU1570995 A AU 1570995A AU 15709/95 A AU15709/95 A AU 15709/95A AU 1570995 A AU1570995 A AU 1570995A AU 1570995 A AU1570995 A AU 1570995A
- Authority
- AU
- Australia
- Prior art keywords
- protein
- papilloma virus
- formed therefrom
- vlps formed
- modified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU15709/95A AU682092C (en) | 1994-01-31 | 1995-01-31 | Modified papilloma virus L2 protein and VLPs formed therefrom |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPM3588 | 1994-01-31 | ||
AUPM3588A AUPM358894A0 (en) | 1994-01-31 | 1994-01-31 | Modified papilloma virus l2 protein and vlps formed therefrom |
PCT/AU1995/000043 WO1995020659A1 (en) | 1994-01-31 | 1995-01-31 | MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM |
AU15709/95A AU682092C (en) | 1994-01-31 | 1995-01-31 | Modified papilloma virus L2 protein and VLPs formed therefrom |
Publications (3)
Publication Number | Publication Date |
---|---|
AU1570995A true AU1570995A (en) | 1995-08-15 |
AU682092B2 AU682092B2 (en) | 1997-09-18 |
AU682092C AU682092C (en) | 1999-01-28 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
AU682092B2 (en) | 1997-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4803196A (en) | Recombinant DNA virus and method for preparation thereof | |
AU5285899A (en) | Anti hepatitis c virus antibody and uses thereof | |
AU4426296A (en) | G protein coupled receptor protein, production, and use thereof | |
AU4597596A (en) | Prevention of protein aggregation | |
AU2064297A (en) | Hepatitis c virus ribozymes | |
AU6124196A (en) | Novel dolastatin derivatives, their preparation and use | |
AU1245297A (en) | Preparation of 1,1,1,3,3-pentachlorobutane and 1,1,1,3,3-pentafluorobutane | |
AU1021997A (en) | Cd100 antigen and uses therefor | |
AU2705395A (en) | Fas associated proteins | |
AU2572797A (en) | Adam proteins and uses thereof | |
AU1416499A (en) | Novel molecules of the follistatin-related protein family and uses therefor | |
AU3159499A (en) | Antigen preparation and use | |
AU7422496A (en) | NM03 antibody materials and methods | |
NZ298224A (en) | Recombinant papilloma virus antigens | |
AU5874798A (en) | Vaccination methods and molecules | |
AU4553697A (en) | Immunogenic peptides of foot-and-mouth disease viruses | |
AU7238098A (en) | Peptides having cyclic structures and exerting p53 protein activty-restoring effect on p53 protein mutants | |
AU3451397A (en) | Modified protein g and fragments thereof | |
AU1689099A (en) | Coagulation precipitator | |
AU7495796A (en) | Novel oligopeptides, the preparation and use thereof | |
AU4554899A (en) | Novel hepatitis c virus peptides and uses thereof | |
HUP9801330A3 (en) | Novel pka-binding proteins and uses thereof | |
AU4690096A (en) | Phosphotyrosine assay and peptides for use therein | |
AU1570995A (en) | Modified papilloma virus l2 protein and vlps formed therefrom | |
AU6301698A (en) | Anti-hiv peptides and proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK14 | Patent ceased section 143(a) (annual fees not paid) or expired | ||
NA | Applications received for extensions of time, section 223 |
Free format text: AN APPLICATION TO EXTEND THE TIME FROM 20000131 TO 20001031 IN WHICH TO PAY A RENEWAL FEE HAS BEEN LODGED |
|
NB | Applications allowed - extensions of time section 223(2) |
Free format text: THE TIME IN WHICH TO PAY A RENEWAL FEE HAS BEEN EXTENDED TO 20001031 |